Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bullock

Showing results (161-170 of 220) with videos related to

Pageof 22
Sort By:
The Journal of Experimental Medicine|August 19, 2009
Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migrationRebekka Grundler, Laurent Brault, Christelle Gasser, et al.
Cell Death and Differentiation|September 19, 2009
Conformational stability and activity of p73 require a second helix in the tetramerization domainD Coutandin, F Löhr, F H Niesen, et al.
BJC Reports|February 5, 2024
Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancerNavid Sobhani, Dana Rae Tardiel-Cyril, Dafei Chai, et al.
Chemistry & Biology|September 1, 2015
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase InhibitorsPeter Canning, Qui Ruan, Tobias Schwerd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Plos One|August 31, 2013
Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1Edmond M Linossi, Indu R Chandrashekaran, Tatiana B Kolesnik, et al.
Neuro-Oncology Advances|February 10, 2026
The influence of VEGFR-2 blockade and focused ultrasound blood-brain barrier opening on the glioma-immune landscapeKatherine M Nowak, Matthew R Hoch, Victoria R Breza, et al.
The Journal of Biological Chemistry|January 26, 2013
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligasesPeter Canning, Christopher D O Cooper, Tobias Krojer, et al.
Molecular and Cellular Biology|September 14, 2017
Correction for Bagarova et al., "Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation"Jana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Molecular and Cellular Biology|April 11, 2013
Constitutively active ALK2 receptor mutants require type II receptor cooperationJana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Pageof 22

Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
The Journal of Experimental Medicine|August 19, 2009
Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migrationRebekka Grundler, Laurent Brault, Christelle Gasser, et al.
Cell Death and Differentiation|September 19, 2009
Conformational stability and activity of p73 require a second helix in the tetramerization domainD Coutandin, F Löhr, F H Niesen, et al.
BJC Reports|February 5, 2024
Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancerNavid Sobhani, Dana Rae Tardiel-Cyril, Dafei Chai, et al.
Chemistry & Biology|September 1, 2015
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase InhibitorsPeter Canning, Qui Ruan, Tobias Schwerd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Plos One|August 31, 2013
Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1Edmond M Linossi, Indu R Chandrashekaran, Tatiana B Kolesnik, et al.
Neuro-Oncology Advances|February 10, 2026
The influence of VEGFR-2 blockade and focused ultrasound blood-brain barrier opening on the glioma-immune landscapeKatherine M Nowak, Matthew R Hoch, Victoria R Breza, et al.
The Journal of Biological Chemistry|January 26, 2013
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligasesPeter Canning, Christopher D O Cooper, Tobias Krojer, et al.
Molecular and Cellular Biology|September 14, 2017
Correction for Bagarova et al., "Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation"Jana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Molecular and Cellular Biology|April 11, 2013
Constitutively active ALK2 receptor mutants require type II receptor cooperationJana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Pageof 22